"Oxfam's report is a timely reminder that any real effort to end poverty has to confront the public policy choices that create and sustain inequality." — Professor Joseph Stiglitz, Columbia University, winner of the Nobel Prize for Economics.
The National Union of Public and General Employees (NUPGE) has provided a donation of $25,000 to international efforts to respond to the Ebola epidemic in Western Africa. Realizing that the crisis requires a greater response from the international community, NUPGE has called on the Conservative government to step up with more resources.
"The National Union is strongly committed to the campaign to win the release of the remaining members of the Cuban 5 who are unjustly held in U.S. prisons," said James Clancy, NUPGE National President.
"We have exciting work ahead, full of new conversations about how to make our country, our communities, our workplaces and our lives better. And we want you to continue to be part of it!" - James Clancy, NUPGE National President.
Harper government trying to undermine sustainable development at UNCTAD conference in Doha today, say Canadian civil society organizations.
"As the trade union movement has well pointed out, it is growth and decent jobs, not austerity, which are essential to beating the crisis and putting an end to the growing inequality and poverty around the globe." - James Clancy, NUPGE National President.
"The Colombian authorities must take every action necessary to end this constant violence against the trade union movement, as well as the impunity surrounding these crimes," said ITUC General Secretary Sharan Burrow.
'We Are One' events to take place across the U.S. on April 4, the 43rd anniversary of the day Dr. Martin Luther King Jr. was assassinated after speaking in Memphis, Tennessee on behalf of striking black sanitation workers.
One more fight ahead as the bill now goes before the Senate where it will face a challenge by some government-appointed Senators intent on blocking passage of the bill.
Bill to reform program intended to provide access to low cost generic drugs to developing countries faces opposition from big pharma lobbyists.